TrialNature medicine2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Joris L Vos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled ittrialcites it
TrialNature medicine2023
Joris L Vos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.